These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10628771)

  • 1. Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation.
    Rosen HR; Lentz JJ; Rose SL; Rabkin J; Corless CL; Taylor K; Chou S
    Transplantation; 1999 Dec; 68(12):1898-902. PubMed ID: 10628771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.
    Rosen HR; McHutchison JG; Conrad AJ; Lentz JJ; Marousek G; Rose SL; Zaman A; Taylor K; Chou S
    Am J Gastroenterol; 2002 Mar; 97(3):714-20. PubMed ID: 11922568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
    Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
    Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C.
    Dai CY; Chuang WL; Lee LP; Chen SC; Hou NJ; Lin ZY; Hsieh MY; Hsieh MY; Wang LY; Chang WY; Yu ML
    J Viral Hepat; 2006 Nov; 13(11):770-4. PubMed ID: 17052277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft TNFbeta and IL16 polymorphisms influence HCV recurrence and severity after liver transplantation.
    Kimball P; Baker M; Fisher RA
    Liver Transpl; 2006 Feb; 12(2):247-52. PubMed ID: 16447204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury.
    Rosen HR; Gretch DR; Oehlke M; Flora KD; Benner KG; Rabkin JM; Corless CL
    Transplantation; 1998 May; 65(9):1178-82. PubMed ID: 9603164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation.
    Sahoo S; Kang S; Supran S; Saloman R; Wolfe H; Freeman RB
    Transplantation; 2000 Mar; 69(5):880-4. PubMed ID: 10755544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    J Heart Lung Transplant; 2001 Dec; 20(12):1265-73. PubMed ID: 11744409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation. NEMC TNF Study Group. New England Medical Center Tumor Necrosis Factor.
    Freeman RB; Tran CL; Mattoli J; Patel K; Supran S; Basile FG; Krishnamurthy S; Aihara R
    Transplantation; 1999 Apr; 67(7):1005-10. PubMed ID: 10221485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-α promoter gene polymorphisms are not associated with hepatitis C virus infection in Chinese hemodialysis patients.
    Zhang X; Hu D; Zhu B; Wang C; He J; Wu J; Yu RB; Zhao WH
    Ren Fail; 2011; 33(6):593-9. PubMed ID: 21631181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
    Killackey MT; Gondolesi GE; Liu LU; Paramesh AS; Thung SN; Suriawinata A; Nguyen E; Roayaie S; Schwartz ME; Emre S; Schiano TD
    Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus.
    Goyal A; Kazim SN; Sakhuja P; Malhotra V; Arora N; Sarin SK
    J Med Virol; 2004 Jan; 72(1):60-5. PubMed ID: 14635012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection.
    Abdallah AN; Cucchi-Mouillot P; Biteau N; Cassaigne A; Haras D; Iron A
    Eur J Immunogenet; 1999 Aug; 26(4):249-55. PubMed ID: 10457886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.
    Satapathy SK; Fiel MI; Vanatta JM; Del Rio Martin J; Schiano TD
    Exp Clin Transplant; 2013 Dec; 11(6):522-9. PubMed ID: 23901801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients.
    Fernandes H; Koneru B; Fernandes N; Hameed M; Cohen MC; Raveche E; Cohen S
    Transplantation; 2002 Jun; 73(12):1886-91. PubMed ID: 12131682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation.
    Mas VR; Fisher RA; Maluf DG; Archer KJ; Contos MJ; Mills SA; Shiffman ML; Wilkinson DS; Oliveros L; Garrett CT; Ferreira-Gonzalez A
    Clin Genet; 2004 Mar; 65(3):191-201. PubMed ID: 14756669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.